Abstract
Purpose
To explore the prevalence of nocturnal intermittent hypoxemia (NIH) in a tertiary hospital geriatric department and the relationship between NIH and mild cognitive impairment (MCI) in older adults, and to examine the role of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism.
Methods
Older adults aged ≥ 60 were enrolled. NIH and cognitive assessments were conducted. BDNF concentrations and BDNF Val66Met polymorphism were detected for a preliminary exploration of the possible mechanism of the process.
Results
Of 325 older adults enrolled, 157 (48%) had NIH and were further divided into mild, moderate, and severe NIH groups according to their oxygen desaturation of ≥ 4% per hour of sleep (ODI4). MCI detection rate in the four groups gradually increased, and the differences were statistically significant (chi-square = 4.457, P = 0.035). ODI4 was negatively correlated with MoCA score in all participants (r = − 0.115, P = 0.039) and patients with NIH (r = − 0.199, P = 0.012). After adjusting for sex, age, and cardiovascular risk factors, NIH and MCI remained independently associated (OR = 3.13, 95% CI 1.03–9.53, P = 0.045). BDNF levels were positively correlated with MoCA score (r = 0.169, P = 0.028) and negatively correlated with nocturnal average oxygen saturation in patients with NIH (r = − 0.288, P = 0.008). Older adults with different BDNF Val66Met genotypes did not show significant differences in MCI rate and BDNF levels (P > 0.05).
Conclusion
The older adults with NIH have a higher MCI detection rate. BDNF levels may be a potential biomarker for cognitive dysfunction in patients with NIH.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
Abbreviations
- NIH:
-
Nocturnal intermittent hypoxemia
- MCI:
-
Mild cognitive impairment
- BDNF:
-
Brain-derived neurotrophic factor
- ODI4:
-
Oxygen desaturation of ≥ 4% per hour of sleep
- ADL:
-
Activities of daily living scale
- MoCA:
-
Montreal Cognitive Assessment
- GAD-7:
-
Generalized Anxiety Disorder Scale-7
- PHQ-9:
-
Patient Health Questionnaire-9
- PSG:
-
Polysomnography
- CI:
-
Confidence interval
- SNP:
-
Single-nucleotide polymorphism
- AHI:
-
Apnea-hypopnea index
References
Leng Y, McEvoy CT, Allen IE, Yaffe K (2017) Association of sleep-disordered breathing with cognitive function and risk of cognitive impairment: a systematic review and meta-analysis. JAMA Neurol 74(10):1237–1245. https://doi.org/10.1001/jamaneurol.2017.2180
Yaffe K, Laffan AM, Harrison SL et al (2011) Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 306(6):613–619. https://doi.org/10.1001/jama.2011.1115
Liu T, Li H, Colton JP, Ge S, Li C (2020) The BDNF Val66Met polymorphism, regular exercise, and cognition: a systematic review. West J Nurs Res 42(8):660–673. https://doi.org/10.1177/0193945920907308
Brzecka A (2005) Brain preconditioning and obstructive sleep apnea syndrome. Acta Neurobiol Exp (Wars) 65(2):213–220
Quialheiro A, Bobinski F, Haefliger JG, et al (2021) A comprehensive program of cognitive stimulation with digital inclusion, physical activity and social interaction can modify BDNF levels and improve cognition in adults over 50: a randomized controlled pilot study. Aging Ment Health :1–9. https://doi.org/10.1080/13607863.2021.1966742
Xia H, Wang M, Li JQ et al (2019) The influence of BDNF Val66Met polymorphism on cognition, cerebrospinal fluid, and neuroimaging markers in non-demented elderly. J Alzheimers Dis 68(1):405–414. https://doi.org/10.3233/JAD-180971
Ferrer A, Labad J, Salvat-Pujol N et al (2019) BDNF genetic variants and methylation: effects on cognition in major depressive disorder. Transl Psychiatry 9(1):265. https://doi.org/10.1038/s41398-019-0601-8
Lim YY, Maruff P, Barthelemy NR et al (2022) Association of BDNF Val66Met with Tau hyperphosphorylation and cognition in dominantly inherited Alzheimer disease. JAMA Neurol 79(3):261–270. https://doi.org/10.1001/jamaneurol.2021.5181
Ren QG, Chang JH, Lu WJ, Gong WG, Zhou H (2017) Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients. Neurol Sci 38(9):1691–1696. https://doi.org/10.1007/s10072-017-3048-9
Flores KR, Viccaro F, Aquilini M et al (2020) Protective role of brain derived neurotrophic factor (BDNF) in obstructive sleep apnea syndrome (OSAS) patients. PLoS One 15(1):e0227834. https://doi.org/10.1371/journal.pone.0227834
Thavagnanam S, H’Ng SY, Nathan AM et al (2021) WRISTOX2 is a reliable tool to diagnose obstructive sleep apnoea syndrome. Int J Pediatr Otorhinolaryngol 151:110930. https://doi.org/10.1016/j.ijporl.2021.110930
Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study Sleep Heart Health Study. JAMA 283(14):1829–1836. https://doi.org/10.1001/jama.283.14.1829
Frohnhofen H, Roffe C (2012) Intermittent nocturnal hypoxemia in individuals with dementia: prevalence and relationship with functional status. J Am Geriatr Soc 60(10):1997–1999. https://doi.org/10.1111/j.1532-5415.2012.04183.x
Tan JP, Li N, Gao J et al (2015) Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population. J Alzheimers Dis 43(4):1403–1412. https://doi.org/10.3233/JAD-141278
Ciesielska N, Sokolowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kedziora-Kornatowska K (2016) Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol 50(5):1039–1052. https://doi.org/10.12740/PP/45368
Winblad B, Palmer K, Kivipelto M et al (2004) Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256(3):240–246. https://doi.org/10.1111/j.1365-2796.2004.01380.x
Akberzie W, Hesselbacher S, Aiyer I, Surani S, Surani ZS (2020) The prevalence of anxiety and depression symptoms in obstructive sleep apnea. Cureus 12(10):e11203. https://doi.org/10.7759/cureus.11203
Emilsson OI, Benediktsdottir B, Olafsson I et al (2016) Erratum to: respiratory symptoms, sleep-disordered breathing and biomarkers in nocturnal gastroesophageal reflux. Respir Res 17(1):130. https://doi.org/10.1186/s12931-016-0448-y
Lee SA, Kim HJ, Lee Y (2020) Subjective nocturnal symptoms have different associations with depressive symptoms and anxiety than with daytime sleepiness in patients with obstructive sleep apnea. Sleep Med 69:58–64. https://doi.org/10.1016/j.sleep.2019.12.019
Park KM, Kim SY, Sung D et al (2019) The relationship between risk of obstructive sleep apnea and other sleep problems, depression, and anxiety in adolescents from a community sample. Psychiatry Res 280:112504. https://doi.org/10.1016/j.psychres.2019.112504
Santos RS, Motwani SS, Elias RM (2016) Chronic kidney disease and sleeping disordered breathing (SDB). Curr Hypertens Rev 12(1):43–47. https://doi.org/10.2174/1573402112666160114094222
Sawatari H, Chishaki A, Ando SI (2016) The epidemiology of sleep disordered breathing and hypertension in various populations. Curr Hypertens Rev 12(1):12–17. https://doi.org/10.2174/1573402112666160114093307
Yazici O, Hatipoglu ON (2019) Evaluation of quality of life, anxiety, and depression in the spouses of patients with obstructive sleep apnea syndrome. Niger J Clin Pract 22(4):516–520. https://doi.org/10.4103/njcp.njcp_500_18
Peltz CB, Corrada MM, Berlau DJ, Kawas CH (2011) Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments. Neurol 77(21):1906–1912. https://doi.org/10.1212/WNL.0b013e318238ee89
Bekinschtein P, Cammarota M, Medina JH (2014) BDNF and memory processing. Neuropharmacol 76(PT C):677–683. https://doi.org/10.1016/j.neuropharm.2013.04.024
Notaras M, van den Buuse M (2019) Brain-derived neurotrophic factor (BDNF): novel insights into regulation and genetic variation. Neurosci 25(5):434–454. https://doi.org/10.1177/1073858418810142
Yu H, Zhang Z, Shi Y et al (2008) Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry 69(7):1104–1111. https://doi.org/10.4088/jcp.v69n0710
Franzmeier N, Ren J, Damm A et al (2021) The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease. Mol Psychiatry 26(2):614–628. https://doi.org/10.1038/s41380-019-0404-6
Chen SL, Lee SY, Chang YH et al (2015) The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese heroin-dependent patients. Sci Rep 5:8148. https://doi.org/10.1038/srep08148
Wang Y, Zhang H, Li Y et al (2015) BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder. J Affect Disord 186:7–12. https://doi.org/10.1016/j.jad.2015.07.023
Chan MTV, Wang CY, Seet E et al (2019) Association of unrecognized obstructive sleep apnea with postoperative cardiovascular events in patients undergoing major noncardiac surgery. JAMA 321(18):1788–1798. https://doi.org/10.1001/jama.2019.4783
Acknowledgements
The authors thank Jiaojiao Li, Chenzhao Zhao, and Min Zhang for their work in cognitive evaluation.
Funding
This work was supported by funding from the Beijing Municipal Science and Technology Committee (D171100008217005).
Author information
Authors and Affiliations
Contributions
DLH, WJT, and CLX devised and designed the study and contributed to the analyses. DLH, GJX, XQ, and JJ collected and analyzed data. DLH and WJT wrote the initial draft of the manuscript and revised it. All authors have read and approved the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was approved by the ethical committee of the Peking University People’s Hospital, and all participants provided written informed consent. The study followed the guidelines of the Declaration of Helsinki.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Deng, L.H., Geng, J.X., Xue, Q. et al. Correlation between nocturnal intermittent hypoxemia and mild cognitive impairment in the older adult and the role of BDNF Val66Met polymorphism: a hospital-based cross-sectional study. Sleep Breath 27, 1945–1952 (2023). https://doi.org/10.1007/s11325-022-02772-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-022-02772-2